Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtypeHannah E. Wilson(Morgantown High School), Emidio E. Pistilli(West Virginia University)npj Breast CancerJune 4, 202010.1038/s41523-020-0162-2Cited by 31SaveCiteExport RISWatch citationsRelated PapersTargeting the Activin Type IIB Receptor to Improve Muscle Mass and Function in the mdx Mouse Model of Duchenne Muscular Dystrophy|American Journal Of Pathology|2011|107Breast cancer associated muscle fatigue: Novel targets to improve survival and quality of life|Unknown|2020|0